Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
2023
53 citations
Journal Article
gold Open Access
Field-Weighted Citation Impact:
13.64
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer | Researchclopedia
Pfizer (United States)
Ahrum Min
·
Seoul National University Hospital
Vinícius Bonato
·
Pfizer (United States)
Seri Park
·
Seoul National University Hospital
Sripad Ram
·
Pfizer (United States)
Dae‐Won Lee
·
Seoul National University Hospital
Ji‐Yeon Kim
·
Samsung Medical Center
Su Kyeong Lee
·
Samsung Medical Center
Won‐Woo Lee
·
Pfizer (United States)
Ji‐Sook Lee
·
Pfizer (United States)
Miso Kim
·
Seoul National University Hospital
Hyun Seon Kim
·
Pfizer (South Korea)
Scott L. Weinrich
·
Pfizer (United States)
Han Suk Ryu
·
Seoul National University Hospital
Tae Yong Kim
·
Seoul National University Hospital
Stephen G. Dann
·
Pfizer (United States)
Yujin Kim
·
Seoul National University Hospital
Diane R. Fernandez
·
Pfizer (United States)
Jiwon Koh
·
Seoul National University Hospital
Shuoguo Wang
·
Pfizer (United States)
Song Yi Park
·
Seoul National University Hospital
Shibing Deng
·
Pfizer (United States)
Eric L. Powell
·
Pfizer (United States)
Rupesh Kanchi Ravi
·
Pfizer (United States)
Jadwiga Biénkowska
·
Pfizer (United States)
Paul A. Rejto
·
Pfizer (United States)
Woong‐Yang Park
·
Samsung Medical Center
Zhengyan Kan
·
Pfizer (United States)